# Latigo Bio

**Canonical:** https://apis.io/providers/latigo-bio/  
**Website:** https://latigobio.com/  
**APIs profiled:** 0

Latigo Biotherapeutics, Inc. ("Latigo Bio") is a clinical-stage biotechnology company headquartered in Thousand Oaks, California, developing novel non-opioid medicines for acute and chronic pain. Its lead candidates LTG-001 and LTG-321 are oral NaV1.8 sodium-channel inhibitors targeting pain at its peripheral source without the addiction risk of opioids; LTG-001 holds FDA Fast Track designation and reported positive Phase 2b results in post-abdominoplasty acute pain, published in the New England Journal of Medicine in July 2026. The company was founded on human-genetics-validated targets and uses in-house AI/ML and structure-based drug design to optimize potency and selectivity. It debuted in 2024 with a $135M Series A and closed a $150M Series B in March 2025, backed by Westlake Village BioPartners, 5AM Ventures, Foresite Capital and Corner Ventures. Latigo is a therapeutics developer, not a software vendor: it publishes no public API, developer portal, SDK or machine-readable specification.

## Kin Score — 9.8 / 100 (minimal)

Scored 2026-08-25 under rubric 0.14.0. Trend: flat (+0.0 from 9.8).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 2.9 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | yes |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Latigo Bio Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Drug Discovery, Clinical Trials, Healthcare, Pain Management, Therapeutics

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/latigo-bio/). Scores are computed from the provider's own public artifacts under a published rubric.